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In 2013,  four  Italian  Gastroenterological  Societies  (the  Italian  Society  of  Paediatric  Gastroenterology,
Hepatology  and  Nutrition,  the  Italian  Society  of  Hospital  Gastroenterologists  and  Endoscopists,  the  Italian
Society of  Endoscopy,  and  the  Italian  Society  of  Gastroenterology)  formed  a  joint  panel  of  experts  with
the  aim of  preparing  an ofﬁcial  statement  on transition  medicine  in  Gastroenterology.
The  transition  of adolescents  from  paediatric  to adult care  is  a  crucial  moment  in  managing  chronic  dis-
eases  such  as celiac  disease,  inﬂammatory  bowel  disease,  liver  disease  and  liver  transplantation.  Improved
medical  treatment  and  availability  of  new  drugs  and surgical  techniques  have  improved  the  prognosis
of  many  paediatric  disorders,  prolonging  survival,  thus  making  the  transition  to adulthood  possible  and
necessary.  An inappropriate  transition  or  the  incomplete  transmission  of  data from  the  paediatrician
to  the  adult  Gastroenterologist  can  dramatically  decrease  compliance  to  treatment  and  prognosis  of  a
young patient,  particularly  in the case of severe  disorders.  For  these  reasons,  the  Italian  gastroenterolog-
ical  societies  decided  to  develop  an ofﬁcial  shared  transition  protocol.  The  resulting  document  discusses
the  factors  inﬂuencing  the transition  process  and  highlights  the  main  points  to accomplish  to  optimize
compliance  and  prognosis  of  gastroenterological  patients  during  the difﬁcult  transition  from  childhood
to adolescence  and  adulthood.
©  2015  Editrice  Gastroenterologica  Italiana  S.r.l.  Published  by Elsevier  Ltd.  All  rights  reserved.. Introduction
“Transition is the purposeful, planned movement of adolescents
nd young adults with chronic physical and medical conditions from
 child-centred to an adult-centred healthcare system”  (Blum et al.,
993) [1]. Transition is not just a simple ‘transfer’ of patients from
 paediatric service to an adult care one: transition medicine (TM)
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with paediatric specialists, and aims to make patients independent
in managing their own  health (and disease) [2].
TM deals with critical aspects of care for patients with a chronic
disease of childhood onset, when and as they move from child-
oriented to adult-oriented services [3].
It is a very delicate phase of care provision and management,
inﬂuenced by the particular degree of vulnerability of adolescents
when they are faced with the difﬁculties arising from their age and
disease [4].
The organization of TM is a dynamic process, aiming at ensuring
continuity, coordination, ﬂexibility and sensitivity in a multi-
disciplinary context, to meet the adolescent’s clinical, psycho-social
and educational needs as well as enhance his/her abilities [5].
Although widely discussed in the scientiﬁc literature, a smooth
transition may  encounter obstacles linked to the experience of the
patients and their families (caregivers), as well as of the paedi-
atric and adult health care providers. These obstacles challenge the
adoption of a single preferred model as TM should take into account
a wide range of speciﬁc needs [6]. A speciﬁc TM program has a
complex structure and should include: setting up disease-oriented
 rights reserved.
Liver D
w
a
p
a
s
o
s
m
R
b
d
a
a
e
b
t
i
d
I
s
I
e
a
2
c
p
d
t
f
s
t
r
f
g
d
g
g
s
a
i
c
o
u
w
e
l
t
m
r
w
e
l
3
l
d
iL. Elli et al. / Digestive and 
orking groups at the hospital level including paediatric and
dult gastroenterologists, internists, psychologists, developmental
sychiatrists and other specialists; adopting a shared diagnostic
nd therapeutic work-up; identifying medical and paramedical
taff to involve and the development of speciﬁc training for all
perators; involving health care providers and institutions (e.g.
cientiﬁc societies, voluntary sector associations and local govern-
ent authorities); creating a centralized digital database (Regional
egistry of Pathologies).
For chronic gastrointestinal conditions such as inﬂammatory
owel disease, celiac disease, chronic liver diseases with a pae-
iatric onset, patients should undergo a transition process during
dolescence. That is of paramount relevance for all disorders man-
ged in dedicated centres (e.g. cystic ﬁbrosis, Rendu-Osler disease
tc.) [7]. Present, there are no speciﬁc transition programs endorsed
y the gastroenterological scientiﬁc societies in Italy: this nega-
ively affects both current clinical practice as well as future research
n the ﬁeld.
The above considerations have led the Italian Society of Pae-
iatric Gastroenterology, Hepatology and Nutrition (SIGENP), the
talian Association of Hospital Gastroenterologists and Endo-
copists (AIGO), the Italian Society of Endoscopy (SIED), and the
talian Society of Gastroenterology (SIGE) to call upon a panel of
xperts to develop a set of practical recommendations towards an
ppropriate roadmap for TM in Gastroenterology.
. Methods
In May  2013 a panel of expert Gastroenterologists and Paediatri-
ians members of SIGENP, AIGO, SIGE and SIED, was  established to
repare a position statement on TM for gastroenterological disor-
ers. The panel initially met  on June 4th 2013 in Milan to deﬁne the
imeline and milestones of the document. Regular conference calls
ollowed with Web-based data exchange organized by a dedicated
ecretariat (Area Qualità). The document included the deﬁnition of
he levels of evidence with a >90% agreement among operators.
The panel members carried out a comprehensive PubMed
esearch for English-written articles, without time limits, using the
ollowing Mesh terms: transition medicine, adolescence medicine,
astroenterology, gastrointestinal diseases, inﬂammatory bowel
isease, IBD, Crohn’s disease, ulcerative colitis, celiac disease,
luten-related enteropathy, celiac sprue, dermatitis herpetiformis,
luten free diet, Barrett oesophagus, liver transplantation, cholesta-
is, biliary atresia, Alagille’s syndrome, viral hepatitis, HCV, HBV,
lpha-1 antitrypsin deﬁciency, Wilson’s disease, progressive famil-
al intra-hepatic cholestasis, immunosuppressive therapy, therapy
ompliance. Whenever possible the level of evidence and rec-
mmendations were deﬁned for each statement. The criteria
sed for evidence and recommendations were in accordance
ith the Oxford Center of Evidence-based Medicine, March 2009
dition (www.cebm.net/oxford-centre-evidence-based-medicine-
evels-evidence-march-2009/) and were reported in parentheses at
he end of each statement.
The manuscript was  structured bearing in mind that inﬂam-
atory bowel disease, celiac disease, and chronic liver diseases
epresent the majority of chronic gastroenterological disorders
ith a paediatric onset. For other diseases, such as eosinophilic
sophagitis, one should consider a speciﬁc transition pathway fol-
owing the indications of the literature [8].
. Common aspects of transition during adolescenceAny chronic disease can negatively affect infancy and ado-
escence, deeply inﬂuencing a patient’s physical and mental
evelopment. Both patients and their families should be fully
nformed of these issues. From a young patient’s point of view,isease 47 (2015) 734–740 735
he/she has to deal with the responsibility of balancing social life,
school attendance and health management, while possibly lacking
the cognitive and emotional capabilities needed to comply with a
therapeutic regimen. As a consequence, the rate of adherence to
treatment during adolescence is lower than in other age groups
or other developmental life stages. Limited life experience and a
sense of adolescent ‘invincibility’ may  prevent young patients from
fully understanding their actual state of health. Some young adults
may  also show an apparent reluctance to abandon their paediatric
medical staff and to refuse the support of their own families [1,2].
As widely reported, the crucial issue of switching from a family-
centred (paediatric) care model, with direct involvement of parents
in the diagnostic and therapeutic decision-making process, to self-
managed (adult) care, may  cause a young patient to experience a
sense of exclusion and fear [9].
Even the attitude of the specialists involved can represent an
obstacle to the transition process: paediatric gastroenterologists
and their staff (e.g. nurses, nutritionists, psychologists) potentially
contribute to an unbalanced relationship that bonds them to the
young patients and their families, possibly due to a feeling of
‘exclusivity’ in care (“I know the patient better than anyone else”).
Conversely, it is possible that a physician caring for adult patients
may  lack the experience to manage an adolescent with a childhood-
onset disease [6].
Other potential factors that lead to inadequate TM,  are: insuf-
ﬁcient knowledge by the ‘new’ gastroenterologist of a patient’s
clinical history, adolescent’s resistance to change, family anxiety,
reluctance by the paediatric gastroenterologist to “lose the patient”
or even the difﬁculty to identify a dedicated specialist.
Based on these considerations, it is clear how difﬁcult it is to
deﬁne an ideal age for a patient’s transition, even if it is expected to
occur at the age of 18 years. The patient’s physical and emotional
maturity, the level of disease activity, ‘compliance’ to treatment,
the degree of autonomy in disease management, all represent key
factors inﬂuencing the ideal transition age [10].
Despite the current availability of general recommendations
concerning transition from paediatric to adult Gastroenterolo-
gists, pertinent guidelines or statements for the most appropriate
methodology are still lacking. Patients must be aware of the course
of their chronic disease and the possibility that it would negatively
affect their everyday life or lead to the development of other asso-
ciated diseases. Accordingly, an adult Gastroenterologist should
establish the most appropriate transition time together with the
patient’s family [11]. Moreover, all available support resources
should be taken into account when planning the transition process:
need for referral to a dedicated service for the underlying disease
with both in-house facilities and access to specialized staff (physi-
cians, nurses, etc.) near the patient’s home, and the availability of
an accessible Gastroenterology Unit [12].
Ideally, at the beginning of adolescence, the paediatric Gastroen-
terologist should start to educate both the patient and their family
about transition, with the goal of making the patient gradually
autonomous in the management of his/her chronic disease, there-
fore preparing him/her for the later transfer to an adult facility. This
initial induction should desirably involve a developmental psychol-
ogist. As a result, both patients and their families will become able
to recognize the onset of symptoms, the disease characteristics,
any related complications, the appropriate medications and any
drug-related side effects [12].
Within the healthcare provider unit, regular meetings should be
held during the transition process with all professionals involved.
In particular, the most relevant treatment decisions should be
discussed and shared (i.e., consultation by phone or computer)
between the adult and paediatric Gastroenterologists at the begin-
ning of the transition period; ideally one would create a speciﬁc
‘patient-centric’ network within the regional healthcare facilities.
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he second transition phase should begin when the paediatric Gas-
roenterologist believes the young patient is ready to move on, i.e.
e/she has become independent in disease management and/or
as reached maturity within the age range of 16–20 years. At this
oint, a reassessment should be performed by all involved profes-
ionals to agree on the speciﬁc transition program. The paediatric
astroenterologist should provide the adult counterpart all medi-
al records; ideally, medical records should be easily to allow the
ffective transfer of patient information between specialists. Med-
cal records should be translated if the patient spends a signiﬁcant
eriods abroad for study or family reasons.
Ideally, patients should be in remission from their disease at the
ime of transfer. Otherwise, the involved specialists should coop-
rate to achieve remission during the transition period.
The paediatric Gastroenterologist will provide the informa-
ion concerning the recommended adult Gastroenterology Unit(s),
ased on the speciﬁc disease to be treated, geographic location,
atient’s life projects (e.g. relocation for study or work) and any
ossible preferences. The recommendations are then discussed and
hared with the patient and the family.
Common aspects of the transition program are its duration, the
eeting schedule between paediatric and adult Gastroenterolo-
ists, providing an adequate amount of time for ﬁrst visits, and
elping raise the patient’s awareness and understanding of his/her
ondition by providing printed materials.
During the ﬁnal phase, the transfer is completed and whenever
ossible the paediatric Gastroenterologist would remain available
or approximately one year, should the need for further case dis-
ussion or patient review occur.
For patients suffering from chronic gastroenterological diseases
nd other disabilities and/or cognitive deﬁcits, additional support
hould be provided as required.
.1. The panel’s recommendations
Adolescent patients are generally characterized by low levels
of compliance to therapy and should be strictly monitored
before starting the transition (2c-B).
Although difﬁcult to establish, the ideal age for transition is
between 16 and 20 years, depending on physical and emo-
tional maturity, disease activity, compliance to treatment,
autonomy in disease management (2c-B).
Paediatricians should decide when their young patients are
ready to start the transition program, by taking into account
the above reported factors and with the help of psychologists
when needed (3b-C).
Paediatricians should start the transition program by inform-
ing patients and families or caregivers about the purpose
of transfer to an adult setting; they should be informed on
the disease characteristics, treatments (including side effects)
and how to recognize alarm symptoms. They should also be
informed on the location of available adult centres, taking into
consideration the patient’s wishes and needs (5-D).
The transition process should include a period of overlap
between paediatric and adult care providers; the length of this
period depends on disease severity (5-D).
Regular meetings or suitable Web-based interaction between
paediatric and adult Gastroenterologists should be scheduled
to improve the effectiveness of the transition program (5-D).
. Transition medicine for speciﬁc gastroenterological
iseases.1. Inﬂammatory bowel disease
The course of inﬂammatory bowel disease (IBD) is mainly
hronic-relapsing, characterized by alternate periods of remissionisease 47 (2015) 734–740
and exacerbation. IBDs include Crohn’s disease (CrD), ulcerative
colitis (UC) and indeterminate colitis. Up to 25% of IBDs have an
onset in childhood with a peak in adolescence, showing a rising inci-
dence rate in recent years, especially with regard to CrD [13,14,15].
The increasing number of adolescents with IBD makes it necessary
for both paediatric and adult gastroenterologists to know about the
problems the disease poses in adolescence [16]. Therefore the initial
diagnostic work-up and treatment of paediatric patients (<16 years
of age) should be performed in a Paediatric Department (within
a network of paediatric gastroenterology clinics) with regard to
the speciﬁc problems of paediatric-onset IBD. The current litera-
ture highlights the difﬁculties in managing chronic diseases during
adolescence, such as reduced compliance or even non-adherence
to therapy and follow-up programs. This can lead to worsening
disease control and overall reduction of patient’s quality of life,
potentially leading to a dramatic increase in IBD management costs
[17–19]. As with other chronic diseases, the transition of paedi-
atric IBD patients to adulthood represents a period of vulnerability,
further increased by the serious disease-related growth obstacles
to physiological development, psychological sexual maturity and
acquisition of social skills [18,20].
Importantly, the transition from paediatric to adult care facili-
ties also implies a cultural switch, which is linked to the changes of
the patient’s “care habits”; in fact, the family-centred relationship
system including direct parental involvement in decision-making
and a multi-disciplinary approach, changes to a direct contact
model [21,22]. The patient should be informed that the diagnostic
approach could also be different. For instance, endoscopic exam-
inations may  no longer be performed under heavy sedation and
surveillance colonoscopy would be planned at ten-year intervals
or more frequently when dealing with the most severe forms of
IBD [23]. A shared transition program between paediatric and adult
Gastroenterologists reportedly improves both patient’s progno-
sis and psycho-social well-being. In this context, different studies
reported that, after childhood ends, patients prefer to be treated at
an adult care centre and to be directly responsible for their own
health [24]. There are some distinctive aspects of IBD in the tran-
sition period: they concern the acquisition of speciﬁc knowledge
and skills by both patients and their healthcare providers [25,26].
In detail, educating patients on their transition should start early
and aim at acquiring skills such as understanding disease character-
istics and evolution; understanding complications, infection risk,
neoplastic risk, effects on fertility and pregnancy resulting from
both the disease and its treatment; knowing the names of medi-
cations, their indications, dosing, side effects, how to obtain repeat
prescriptions, and the risks of non-adherence to treatment; know-
ing how to schedule their own appointments and who  to contact in
case of relapse; learning about exemptions and legal rights result-
ing from chronic/disabling diseases; being aware of the available
services dedicated to IBD (e.g. information on the closest adult cen-
tre); learning to ask questions directly to the physician, and the
possibility that a medical examination may  be take place without
parental supervision [27].
Ideally, the transition period should also involve a develop-
mental psychologist, possibly dedicated to IBD. The initial work-up
should be shared between the paediatric and the adult Gastroen-
terologist to facilitate both homogeneity and continuity of care
[28]. During the transfer period it is advisable that the disease
be in remission and the transfer organization should consider in
detail the actual availability of local resources, mainly IBD dedi-
cated services with adequately trained medical and nursing staff
[29,30].Overall, the transition program will last from six to twelve
months, giving priority to the collegial visits (at least once or twice
during this period) by the two lead professionals and to alternative
delivery modes (e.g. alternate visits at the two  care service sites)
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ubject to resources and needs. The involvement of both parents
nd patients is advisable at the beginning. It is useful to start the
ransition gradually, and to ensure that the patient has been given
he most complete information regarding available services and
hysicians.
.1.1. The panel’s recommendations
The transition program in IBD patients should start at 16 years
of age (2c-B).
Transition in IBD should be carried out gradually, taking into
account physical and emotional maturity, disease activity,
compliance to treatment, autonomy in disease management
(2c-B).
Transition should start during disease remission (2c-B).
The paediatrician should start informing the patient about the
transition program; this phase should be followed by at least
one combined visit (paediatric and adult Gastroenterologist)
to be held at the adult centre (the number of combined visits
can be increased depending on the patient’s status) (5-D).
.2. Coeliac disease
Coeliac disease (CD) is a frequent chronic autoimmune
nteropathy with a prevalence of approximately 1:100, a male:
emale ratio of 1:2, and a bi-modal peak of onset (during paediatric
ge and in the IV decade) [7,31].
Currently, the only available treatment for CD is a lifelong
luten-free diet (GFD). Given its chronic nature and the possible
evelopment of co-morbid disorders (i.e. autoimmune and/or neo-
lastic diseases, disorders secondary to chronic inﬂammation or
trophy of the small intestine, such as anaemia and osteoporosis),
D requires on-going medical support, which has shown to improve
he disease outcome and patients’ compliance to GFD [32–37].
The transition phase for young CD patients is pivotal in
aintaining optimal quality of life and a long-term prognosis
omparable to the general population. To date, there is no data
oncerning the transition in CD, although O’Leary et al. [38] have
eported that patients with discountinuous follow-up after the pae-
iatric stage, frequently (50%) abandon GFD. Medical follow-up
herefore is a motivational factor to maintain good dietary com-
liance in about 25% of cases. Poor compliance to GFD among
eenagers can negatively affect both quality of life and clinical
ourse. In fact, a coeliac patient’s quality of life might depend
n whether diagnosis was based on symptoms or obtained after
amily screening. At diagnosis, patients presenting with a typi-
al CD have a relatively low quality of life, which improves with
FD; conversely, the better quality of life of asymptomatic patients
efore the exclusion diet, worsens later owing to the limitations
nd constraints imposed by GFD, in turn reducing the patient’s
otivation to adhere to the prescribed dietary treatment. Para-
oxically, asymptomatic patients diagnosed by screening are at
reater risk of non-adherence to GFD, thus requiring a more strict
ollow-up [39]. Differently from other diseases discussed in this
eport, CD transition is peculiar in that it is characterized by a
igh number of affected subjects and a relatively low incidence
f complications. To effectively enable the transition of paediatric
D patients, it is essential to ensure continuity of care. The transi-
ion can be simply performed via a joint visit by the paediatric and
he adult Gastroenterologist, during which the patient’s needs are
dentiﬁed with respect to his/her expectations and the modalities
or follow-up. ‘Simple’ patients would require both psychological
nd nutritional support. Otherwise, when facing patients with par-
icular co-morbidities (e.g. other autoimmune diseases requiring
hronic therapy or showing an incomplete response to GFD), the
valuation could change over time depending on the equipment
nd the specialists required [40]. Also in these cases, psychologicalisease 47 (2015) 734–740 737
consultation may  be needed and thus the opportunity for two com-
bined visits should be considered. For the subset of CD patients with
optimal clinical response but some difﬁculties in adherence to GFD
during adolescence, consultation with a psychologist is advisable.
4.2.1. The panel’s recommendations
• The transition program in CD patients should start at 16 years
of age (4-C).
• Transition in CD should be started by a paediatrician taking
into account the patient’s physical and emotional maturity
and can include a combined visit (paediatric and adult Gas-
troenterologist) to reduce GFD drop-out rates (2c-B).
• Only in cases of a complicated disease and particular comor-
bidities (i.e., multiple autoimmune diseases), an IBD-type
transition program should be considered (5-D).
4.3. Chronic liver diseases
The aetiology of chronic liver diseases (CLDs) during child-
hood varies signiﬁcantly when compared to CLDs in adulthood.
Many children with complicated CLD can now survive into adult-
hood thanks to specialized medical care. As paediatric CLD patients
receiving treatment of both hepatic and extra-hepatic compli-
cations reach adulthood, the transition to adult care requires a
comprehensive knowledge of paediatric CLD [41].
The transition from paediatric to adult care remains a difﬁcult
process for both patients and their families. Particular attention
must be paid to the nutritional aspects, vaccination status, degree of
sexual development, the presence of extra-hepatic manifestations
and psycho-social implications [42].
A transition program should be considered for the following
CLDs.
4.3.1. Biliary atresia
Biliary atresia (BA) is the result of a destructive inﬂamma-
tory process of the bile ducts inside and outside the liver with
resulting ﬁbrosis and progression to cirrhosis. With an incidence
of 1:5000–12,000 newborns, BA is the most common cause of
chronic cholestasis in infants and the most frequent indication for
liver transplantation in children. A timely diagnosis is crucial as
appropriate treatment ensures a better long-term prognosis. The
Kasai procedure to drain bile ﬂow represents the standard of care.
Children with BA have a variable prognosis; moreover, both short
and long-term complications are common. Approximately 80% of
BA patients will require an orthotopic liver transplant (OLT) and
those reaching adulthood will require strict follow-up. In partic-
ular, women are at increased risk of portal hypertension during
pregnancy [43].
4.3.2. Alagille’s syndrome
This autosomal dominant disorder caused by a defect in the JAG1
gene, affects the liver (paucity of bile ducts and portal ﬁbrosis),
heart, eyes, skeleton, kidneys, causes delayed puberty as well as
a characteristic facies. OLT is performed in approximately 15% of
all patients due to risk of liver failure, for intractable pruritus or
osteodystrophy, and may  be necessary at any age [44].
4.3.3. Alpha-1 antitrypsin deﬁciency
This is an autosomal recessive disease characterized by CLD
and early development of pulmonary emphysema, when severe
phenotypic expression is present. Neonatal jaundice and cholesta-
sis represent key factors and liver damage evolves to ﬁbrosis and
cirrhosis, occurring during childhood or adulthood, possibly pro-
gressing to hepatocellular carcinoma and cholangiocarcinoma. OLT
is currently the only treatment in case of end-stage disease [45].
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.3.4. Progressive familial intra-hepatic cholestasis
This is a heterogeneous group of autosomal recessive disorders
f bile acid transport, with an incidence of 1:50,000 to 1:100,000.
hree distinctive genotypes have been identiﬁed with various phe-
otypes. Patients with PFIC1 and PFIC2 may  present with early
nset of progressive cholestasis, poor growth, intractable pruritus
nd progression to liver failure. Some PFIC1 gene mutations may  be
ssociated with benign recurrent intra-hepatic cholestatic forms
BRIC1). In some patients, cholestatic jaundice crises are associ-
ted with use of oral contraceptives or pregnancy. In patients with
FIC3, the onset of cholestasis is late, sometimes during adoles-
ence. These disorders can be initially treated pharmacologically;
owever, their progression can lead to surgical biliary drainage.
LT is necessary in advanced stages with liver failure and in severe
orms [46].
.3.5. Wilson’s disease
This is an autosomal recessive disease resulting in an accumu-
ation of copper in the liver, central nervous system, cornea and
ther organs. The incidence is 15–30:1 million (heterozygote fre-
uency 1:100). WD presentation is highly variable even in members
f the same family. Liver involvement, always present, may  be clin-
cally silent or lead to acute to fulminant hepatitis. In most cases,
ifelong chelation therapy can control WD progression. However,
on-response to drug therapy and progression to cirrhosis may
equire OLT [47].
.3.6. Autoimmune hepatitis
Many patients with autoimmune hepatitis (AH) are diagnosed
efore the age of 18 years, 75% are females and there is a peak inci-
ence before puberty. Type-1 AH is present in two thirds of all cases
nd occurs in adolescence; type-2 AH occurs in younger children
nd can present as acute liver failure. Lifelong immuno-suppressive
herapies require strict laboratory and imaging follow-up. OLT is
equired when hepatic failure ensues (0.5% to 8% of patients after
–14 years from diagnosis). AH can recur after transplantation in
0% of cases, even several years later [48].
.3.7. Chronic viral hepatitis
Hepatitis C virus (HCV) infection in children is usually transmit-
ed from their HCV-RNA positive mothers in the neonatal period
nd becomes chronic in 80% of cases although often with an
neventful course. Viral replication may  persist until adulthood,
ften with cytolysis. An adequate antiviral regimen including pegy-
ated interferon and ribavirin or, more recently, protease inhibitors,
s standard therapy with a high success rate. OLT may  be required.
epatitis B virus (HBV) infection is frequent among immigrant or
dopted children: 90% of infants and 25–50% of children infected in
arly childhood become chronically infected. The infection is often
symptomatic; treatment of chronically infected children or ado-
escents should be based on their individual immunological status
49,50].
.3.8. Liver transplantation
As mentioned earlier, many CLDs eventually require OLT as
herapy of end-stage liver disease. Adolescents who  are paediatric
iver transplant recipients show an increased risk (17–50%) of non-
dherence to immuno-suppressive therapy [51], which increases
isk of chronic rejection, graft loss and other complications of
ong-term care [52]. This is of paramount importance for plan-
ing the outpatient transition and its appropriate timing, which
hould not be based on a standard procedure but tailored to the
peciﬁc situation and developmental maturity of the individual
atient. Paediatric and adult Gastroenterologists in collaboration
ith other specialists, including specialized paediatric Psychiatrists
nd Hepatologists should perform the assessment, along with theisease 47 (2015) 734–740
corresponding adult specialists in the joint assessment clinic. This
synergistic approach is of relevance also for the adult specialists,
to guide the adult healthcare provider gradually into the peculiari-
ties of each case, while the patients learn to independently manage
their condition, and are gradually released from the support of their
families and former paediatric services.
The results of OLT are usually reported in terms of both organ
and patient survival rates, medical and surgical complications, and
quality of life. However, these conventional parameters are not
always sufﬁcient and appropriate to evaluate the results of OLT in
the teenager population [53,54].
4.3.9. The panel’s recommendations
• The transition program in CLD patients should start between
16 and 18 years of age (2c-B).
• Transition in CLD should be performed gradually, taking into
account the patient’s physical and emotional maturity, dis-
ease activity, compliance to treatment, degree of autonomy in
disease management (2c-B). Because of the severity of many
CLDs and the potential for OLT, psychological support should
be included (2c-B).
• Whenever possible, transition should start during a remission
phase (2c-B).
• The paediatrician should inform the patient about the transi-
tion program; this phase should be followed by four combined
visits (by the paediatric and adult Gastroenterologist) over a
12-month period, to be held, if possible, at a dedicated cen-
tre (Transition Unit), or alternating between the adult and the
paediatric care centres (5-D).
• In this context, the establishment of a transition program is
likely to improve prognosis and reduce costs (3b-B).
5. Organizational issues
Child-to-adult transition projects are ‘easy’ to organize in hospi-
tal settings where both paediatric and adult specialties are in place.
In such a scenario, an agreement should be made between the two
units, endorsed by the health department and aimed at providing
shared outpatient sessions to facilitate the patient’s switch.
The situation is quite different in a paediatric centre, such as
a children’s hospital, lacking adult specialties. In this scenario, it is
essential to refer patients to a pre-arranged service level agreement
between the paediatric and adult hospitals to ensure “privileged
access” during transition. An ideal arrangement would include two
outpatient sessions between the paediatric facility and the adult
referral hospital so that the patient may  become accustomed and
feel conﬁdent with the new physicians and services.
In the case of patients coming from a paediatric facility outside
the region of the adult referral service, a pre-arranged shared pro-
gram may  not be easily accomplished. It is critical in these cases
that appropriate psychological support be provided, with com-
prehensive communication, both verbal and written, between the
paediatrician and the specialist/s of the receiving adult care facility.
This should include forwarding of a detailed clinical report and all
imaging studies carried out during paediatric care.
In the case of a transition between very geographically distant
centres or from other logistical difﬁculties, resorting to internet-
based interfaces can certainly improve contact and information
exchange between paediatric and adult Gastroenterologists [55].
5.1. The panel’s recommendations• When the paediatric and adult centres are not within the
same hospital, a strong collaboration should be established
with regional/remote adult referral services and a preferential
pathway for patients in transition must be  established (5-D).
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Table  1
Characteristics of transition for patients with inﬂammatory bowel disease, celiac disease and chronic liver diseases.
IBD CD CLD
Suggested start age (years) 16 16 16–18
Duration of the transition process
(months)
6–12
Specialists should stay in contact
and/or schedule web conferences to
maintain a uniform follow-up
1
IBD-like transition process to be
considered when dealing with
complicated cases
6
Specialists should stay in contact
and/or schedule web conferences to
maintain a uniform follow-up
Number of combined visits (minimum) 1 or 2 depending on the severity of the
disease
1  4
Location of visits Alternating between the paediatric and
adult gastroenterological services
Adult gastroenterological service Transitional clinic
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[
[
[
[
[
[
[
[Location of service Secondary or tertiary referral centres 
BD, inﬂammatory bowel disease; CD, celiac disease; CLD, chronic liver diseases.
In this scenario alternative, (i.e., internet- based) systems of
medical communication should be considered (5-D).
. Conclusion: why create an outpatient transition?
In order to support patients and their families in the difﬁcult
witch from adolescence to adulthood, healthcare professionals can
elp bring paediatric and adult medicine together by promoting
ffective patient autonomy in disease management and fostering
lose patient-family-physician cooperation (see recommendations
ummarized in Table 1).
The transition team has the delicate task of assisting young
dults and their families in understanding and appreciating the
ultural and practical differences between paediatric and adult
edicine. In fact, with regard to the psychological aspects involved,
hildren and adolescents with chronic diseases are at greater risk of
ong-lasting psychological distress than the general patient popu-
ation, resulting in non-adherence to their treatment and follow-up
egimens. An effective transition can avoid gaps in medical care and
nsure physical and mental well-being during this difﬁcult time.
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